These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7936055)

  • 1. Alpha 1-antichymotrypsin and IL-1 beta are not increased in CSF or serum in Alzheimer's disease.
    Pirttila T; Mehta PD; Frey H; Wisniewski HM
    Neurobiol Aging; 1994; 15(3):313-7. PubMed ID: 7936055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer's disease.
    Sun YX; Minthon L; Wallmark A; Warkentin S; Blennow K; Janciauskiene S
    Dement Geriatr Cogn Disord; 2003; 16(3):136-44. PubMed ID: 12826739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum alpha 1-antichymotrypsin is not a useful marker for Alzheimer's disease or dementia in Parkinson's disease.
    Kuiper MA; van Kamp GJ; Bergmans PL; Scheltens P; Wolters EC
    J Neural Transm Park Dis Dement Sect; 1993; 6(2):145-9. PubMed ID: 8117411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases.
    Williams SM; Schulz P; Sierks MR
    Eur J Neurosci; 2016 Jan; 43(1):3-16. PubMed ID: 26332448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies.
    Nielsen HM; Minthon L; Londos E; Blennow K; Miranda E; Perez J; Crowther DC; Lomas DA; Janciauskiene SM
    Neurology; 2007 Oct; 69(16):1569-79. PubMed ID: 17761554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin.
    Lanzrein AS; Johnston CM; Perry VH; Jobst KA; King EM; Smith AD
    Alzheimer Dis Assoc Disord; 1998 Sep; 12(3):215-27. PubMed ID: 9772027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia.
    Matsubara E; Hirai S; Amari M; Shoji M; Yamaguchi H; Okamoto K; Ishiguro K; Harigaya Y; Wakabayashi K
    Ann Neurol; 1990 Oct; 28(4):561-7. PubMed ID: 2147546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.
    Blum-Degen D; Müller T; Kuhn W; Gerlach M; Przuntek H; Riederer P
    Neurosci Lett; 1995 Dec; 202(1-2):17-20. PubMed ID: 8787820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma and cerebrospinal fluid alpha1-antichymotrypsin levels in Alzheimer's disease: correlation with cognitive impairment.
    DeKosky ST; Ikonomovic MD; Wang X; Farlow M; Wisniewski S; Lopez OL; Becker JT; Saxton J; Klunk WE; Sweet R; Kaufer DI; Kamboh MI
    Ann Neurol; 2003 Jan; 53(1):81-90. PubMed ID: 12509851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute phase reactant alpha 1-antichymotrypsin is increased in cerebrospinal fluid and serum of patients with probable Alzheimer disease.
    Licastro F; Parnetti L; Morini MC; Davis LJ; Cucinotta D; Gaiti A; Senin U
    Alzheimer Dis Assoc Disord; 1995; 9(2):112-8. PubMed ID: 7662323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF levels of PSA and PSA-ACT complexes in Alzheimer's disease.
    Mulder SD; Heijst JA; Mulder C; Martens F; Hack CE; Scheltens P; Blankenstein MA; Veerhuis R
    Ann Clin Biochem; 2009 Nov; 46(Pt 6):477-83. PubMed ID: 19729499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated plasma levels of alpha-1-anti-chymotrypsin in age-related cognitive decline and Alzheimer's disease: a potential therapeutic target.
    Porcellini E; Davis EJ; Chiappelli M; Ianni E; Di Stefano G; Forti P; Ravaglia G; Licastro F
    Curr Pharm Des; 2008; 14(26):2659-64. PubMed ID: 18991685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?
    Licastro F; Pedrini S; Caputo L; Annoni G; Davis LJ; Ferri C; Casadei V; Grimaldi LM
    J Neuroimmunol; 2000 Feb; 103(1):97-102. PubMed ID: 10674995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E2 induced polymerization of human alpha-1-antichymotrypsin and suppressed its protease inhibitory activity: implications for Alzheimer's disease.
    Licastro F; Davis LJ; Pedrini S; Galasko D; Masliah E
    Biochem Biophys Res Commun; 1998 Aug; 249(1):182-6. PubMed ID: 9705853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aging and Alzheimer's disease: protease inhibitors in cerebrospinal fluid.
    Delamarche C; Berger F; Gallard L; Pouplard-Barthelaix A
    Neurobiol Aging; 1991; 12(1):71-4. PubMed ID: 2002886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene polymorphism affecting alpha1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk.
    Licastro F; Pedrini S; Ferri C; Casadei V; Govoni M; Pession A; Sciacca FL; Veglia F; Annoni G; Bonafè M; Olivieri F; Franceschi C; Grimaldi LM
    Ann Neurol; 2000 Sep; 48(3):388-91. PubMed ID: 10976648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha 1-antichymotrypsin level in cerebrospinal fluid is closely associated with late onset Alzheimer's disease.
    Harigaya Y; Shoji M; Nakamura T; Matsubara E; Hosoda K; Hirai S
    Intern Med; 1995 Jun; 34(6):481-4. PubMed ID: 7549128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease.
    Mehta PD; Pirttila T; Patrick BA; Barshatzky M; Mehta SP
    Neurosci Lett; 2001 May; 304(1-2):102-6. PubMed ID: 11335065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum alpha 1-antichymotrypsin in patients with probable Alzheimer's disease: an acute phase reactant without the peripheral acute phase response.
    Licastro F; Morini MC; Polazzi E; Davis LJ
    J Neuroimmunol; 1995 Mar; 57(1-2):71-5. PubMed ID: 7535791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between serum alpha 1-antichymotrypsin and Alzheimer's disease.
    Hinds TR; Kukull WA; Van Belle G; Schellenberg GD; Villacres EC; Larson EB
    Neurobiol Aging; 1994; 15(1):21-7. PubMed ID: 8159260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.